Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF April 21, 2017 | Archived Issues

Meetings and Events


Grand Rounds


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - April 2017 (PDF)


Milestones

Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue.

Submit your milestones and comments.

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

FDA Issues Update on Erythropoiesis-Stimulating Agents

The U.S. Food and Drug Administration recently dropped the Risk Evaluation and Mitigation Strategy requirements for the erythropoiesis-stimulating agent (ESA) products Epogen/Procrit and Aranesp. ESAs are used to treat anemia resulting from chronic kidney disease, chemotherapy and certain treatments for human immunodeficiency virus, and to reduce the number of blood transfusions during and after certain major surgeries.

The FDA website has more information.